申请人:Atkinson Francis Louis
公开号:US20130040984A1
公开(公告)日:2013-02-14
The present invention relates to a compound of formula (I):
or a salt thereof;
which is an inhibitor of spleen tyrosine kinase (Syk) and therefore potentially of use in treating diseases resulting from inappropriate activation of mast and/or basophil cells, macrophages, and B-cells and related inflammatory responses and tissue damage, for instance inflammatory disease and/or allergic disorders, and in cancer therapy, specifically heme malignancies, chronic spontaneous urticaria and autoimmune conditions.
本发明涉及化合物的结构式(I):或其盐;该化合物是脾酪氨酸激酶(Syk)的抑制剂,因此可能用于治疗由于肥大细胞和/或嗜碱性粒细胞、巨噬细胞和B细胞不适当激活引起的疾病,以及相关的炎症反应和组织损伤,例如炎症性疾病和/或过敏性疾病,以及癌症治疗,特别是血液恶性肿瘤、慢性自发性荨麻疹和自身免疫疾病。